Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 07/15/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 07/15/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 07/15/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 07/14/25 | 425 | Prospectuses and communications, business combinations |
|
140 | |
| 07/14/25 | 8-K | Current report |
|
  |
140 |
| 07/02/25 | 8-K | Current report |
|
|
15 |
| 06/02/25 | 8-K | Current report |
|
|
2 |
| 05/13/25 | 10-Q | Quarterly report [Sections 13 or 15(d)] |
|
 |
27 |
| 04/04/25 | 8-K | Current report |
|
|
2 |
| 04/01/25 | 8-K | Current report |
|
|
2 |
